Press "Enter" to skip to content

New patent expiration for Novartis drug TYZEKA

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug TYZEKA

Annual Drug Patent Expirations for TYZEKA
Annual Drug Patent Expirations for TYZEKA

Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug.

This drug has fifty-five patent family members in twenty-one countries.

The generic ingredient in TYZEKA is telbivudine. Additional details are available on the telbivudine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug TYZEKA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!